Cite
APA Citation
Yu, Y., Li, A., Chen, Y., Li, Q., Ou, Q., Lin, D., Zhang, W., Li, Z., Hu, H., & Yao, H. (n.d.). 317OAssociation of survival and blood-based genomic signature with atezolizumab for patients with second-line and third-line EGFR wild-type non-small cell lung cancer: Pooled analysis of individual patient data from the POPLAR and OAK trials. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098037025.0x00002b